Tag - PTQ

Markets

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Raymond James raised its price target for Protech Home Medical (TSXV:PTQ) to $3 (Canadian) from $2.00, citing an update to its valuation methodology. The stock closed at $2.05 on Jan. 21. Protech is a provider of...

January 22, 2021

Markets

Leede Jones Gable starts Protech Home Medical at buy; PT $3.25

Leede Jones Gable initiated coverage of Protech Home Medical (TSXV:PTQ) with a “buy” rating and price target of $3.25. The stock closed at $1.47 on Dec. 18. Protech is a durable medical equipment (DME) and home...

December 21, 2020

Markets

Echelon ascribes Top Pick status to Centric Health, Protech Home Medical

Echelon Wealth Partners ascribed Top Pick status to Centric Health (TSX:CHH) and Protech Home Medical (TSXV:PTQ), while maintaining “buy” ratings and price targets of 25 cents and $2.50, respectively. Shares of Centric...

April 3, 2020

Markets

Echelon starts Protech Home Medical at buy; PT $2.50

Echelon Wealth Partners launched overage of Protech Home Medical (TSXV:PTQ) with a “buy” rating and price target of $2.50. The stock closed at 91 cents on Jan. 22. “We believe the firm is well positioned within [the...

January 22, 2020

Tag - PTQ

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Leede Jones Gable starts Protech Home Medical at buy; PT $3.25

Echelon ascribes Top Pick status to Centric Health, Protech Home Medical

Echelon starts Protech Home Medical at buy; PT $2.50

General

More